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 Abstract  
Many patients with neuropathic pain present without signs of nerve injury on routine clinica l 
examination. Some of these patients may have inflamed peripheral nerves (neuritis). In this 
study, we have examined whether neuritis causes changes within the dorsal horn that may 
contribute to a central pain mechanism. Comparisons have been made to a model of axonal 
transport disruption induced using vinblastine, since neuritis disrupts such processes. At the 
peak of cutaneous hypersensitivities, recordings from wide dynamic range (WDR) neurons 
revealed increases in wind-up following neuritis but not vinblastine treatment. Ongoing activity 
from these neurons was unchanged. Vinblastine treatment caused a reduction in the responses 
of WDR neurons to noxious mechanical stimulation of the receptive field. The response of 
neurons to innocuous mechanical stimulation was also reduced in WDR neurons that were at a 
depth ≥550 µm following vinblastine treatment. An examination of the superficial dorsal horn 
revealed an increase in c-Fos-positive neurons in both groups following electrical stimula t ion 
of the sciatic nerve. The area of dorsal horn expressing substance P was also decreased 
following vinblastine treatment. These findings indicate that a minor nerve insult, such as 
neuritis, can lead to changes within the dorsal horn that are consistent with a central neuropathic 
pain mechanism.  
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Introduction 
Patients diagnosed with conditions such as non-specific arm or back pain, complex regional 
pain syndrome, whiplash associated disorder and fibromyalgia often lack signs of frank nerve 
injury on routine clinical examination despite symptoms that are typically neuropathic in 
origin. Evidence from a model of local nerve trunk inflammation (neuritis) suggests that some 
of these patients have inflamed nerves. In this model, animals rapidly develop transient tactile -  
and thermal-evoked cutaneous hypersensitivities in the absence of axonal degeneration or 
demyelination.1-3 Furthermore, through-conducting nociceptor axons become ongoing and 
respond to direct mechanical stimulation at the inflammatory site,3-6 which may underlie 
spontaneous and movement-evoked radiating pain that are frequently reported in many of these 
patients. Although neuritis cannot easily be detected on routine clinical examination, magnetic 
resonance imaging of the upper limb peripheral nerve trunks in patients with whiplash-
associated disorder and diffuse chronic pain syndromes have revealed changes that are 
consistent with such pathology.7, 8 
The diffuse and often widespread nature of symptoms in these patients has led to the suggestion 
that some symptoms, such as cutaneous hypersensitivities, are centrally-mediated through 
spinal mechanisms.9 Despite studies into the properties of primary sensory neurons following 
neuritis, spinal cord neurons have not been examined. In contrast, a number of studies have 
examined the excitability of dorsal horn neurons following nerve ligation and transection, as 
well as following chronic hind paw inflammation, which dissimilar to neuritis, is associated 
with significant edema,10 and inflammation of the axon terminals. These studies have  
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demonstrated increases in ongoing activity11-15 and receptive field size,15-18 which are in line 
with a central pain mechanism. The majority of electrophysiological studies have focused on a 
subpopulation of dorsal horn neurons known as wide-dynamic range (WDR) neurons. These 
neurons display a frequency dependent increase in excitability to repetitive noxious input, 
called wind-up, that shows similarities with central sensitization.19 Consistent with such 
processes, increases in wind-up have been reported in models of chronic hind paw and joint 
inflammation. 20-22  
In the present study, we have looked for signs of increased excitability in dorsal horn neurons 
following neuritis. We have specifically focused on WDR neurons in the deep dorsal horn (i.e. 
lamina V region). We have also examined c-Fos expression in the superficial dorsal horn in 
response to electrical stimulation of the sciatic nerve, since these neurons were not examined 
electrophysiologically. Although the precise role of c-Fos in pain pathways is not well 
understood, it is a recognized marker of injury-induced and noxious neuronal activation,23 as 
well as an indirect indicator of central sensitization.24 Accordingly, c-Fos expression in the 
superficial dorsal horn is increased following nerve injury.25-27 In addition, we have assessed 
substance P levels in the superficial dorsal horn as a measure of altered nociceptor transmiss ion 
into the spinal cord, since changes have been reported following nerve injury28-30 and chronic 
hind paw inflammation.31, 32 
We have previously shown that neuritis disrupts fast anterograde axonal transport, and have 
hypothesized that such altered processes are important in the mechanisms that lead to pain.33  
The role of axonal transport disruption along intact, through conducting axons can be examined 
without inflammation by applying low doses of the vinca alkaloid, vinblastine, to the sciatic  
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nerve.34-38 Following vinblastine treatment, animals develop tactile-evoked cutaneous 
hypersensitivity and nociceptor axons respond to mechanical stimulation at the treatment 
site.33, 34, 38 To determine whether axonal transport disruption contributes to central processes, 
we have compared neuritis to vinblastine treatment. To confirm the optimum time-point for the 
assessment of dorsal horn neurons, neuropathic pain behaviors were also examined. Together, 
our findings show that neuritis causes changes in the dorsal horn that may contribute to a central 
neuropathic pain mechanism. 
Materials and methods 
Animals 
Experiments were carried out in strict accordance with the UK Animals (Scientific Procedures) 
Act (1986) and Home Office guidelines. Adult male Sprague Dawley rats (n = 97; 175-500g; 
Charles River Laboratories, Kent, UK) were used in this study. Rats were housed in groups of 
2-4 in cages with sawdust and soft nesting material, and were given ad libitum access to food 
and water. Animals were monitored daily for adverse effects. 
 
Surgery 
Neuritis was induced as previously described (n = 30 animals).33 Under general anesthesia 
(1.75% isoflurane in oxygen), a short incision parallel to the femur was made through the skin 
in the mid-thigh on the left side. The underlying muscle was separated by blunt dissection to 
expose the sciatic nerve, and the connective tissue surrounding an 8 mm length of the nerve  
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was carefully cleared. A length of sterile Gelfoam (SpongostanTM; Ferrosan, Denmark), ~6 x 
20 x 2 mm, saturated in 50% complete Freund’s adjuvant (diluted in sterile 0.9% w/v saline) 
was wrapped loosely around the sciatic nerve, and the muscle and skin were closed with 4/0 
monofilament sutures (Vicryl; Ethicon, West London, United Kingdom).  
Vinblastine (n = 27 animals) and saline (n = 17 animals) were applied to the sciatic nerve as 
previously described.33 The left sciatic nerve was exposed in the mid-thigh by blunt dissection 
and the connective tissue surrounding an 8 mm length of the nerve was carefully cleared. A 
strip of sterile parafilm (Sigma Aldrich, Dorset, UK), ~6 x 20 mm, was positioned under the 
nerve to prevent leakage of agents onto the underlying muscle. A length of Gelfoam (~6 x 20 
x 2 mm) saturated in either 0.1 mM vinblastine (diluted 0.9% w/v saline) or 0.9% w/v saline 
was wrapped loosely around the nerve. After 15 min, both the Gelfoam and parafilm were 
removed, and the nerve was rinsed with sterile saline. The muscle and skin were closed with 
sutures.  
 
Behavior 
Behavioral testing was always performed at the same time on each day. Animals were 
habituated to the test apparatus for 1 hour on 3 consecutive days before the start of the testing 
period. On the day of testing, animals were acclimatized for 15 min to allow exploration and 
major grooming activities to cease. For each behavior, both hind paws were tested with a 5 min 
rest period between sides. The side to be tested first was randomized. Six animals were  
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examined in each treatment group. Tactile- and cold-evoked hypersensitivities were tested on 
different animals.  
Tactile-evoked hypersensitivity was assessed using calibrated von Frey filaments of increasing 
stiffness (0.4, 0.7, 1.2, 2, 4, 6, 9, 15 g; Ugo Basile, Varese, Italy) on days 1, 4, 5, 6, 7, 8 and 11 
postoperative. Animals were placed into individual acrylic glass enclosures raised on a metal 
perforated floor. Von Frey hairs were applied perpendicular to the plantar surface of the 
glabrous foot and held for 5 seconds. A positive response was recorded if the paw was sharply 
withdrawn, held or licked. Paw movements due to postural changes were not considered to be 
positive responses. The 50% paw withdrawal threshold was determined using the up-down 
method.39, 40 Testing commenced with the 2.0 g hair. If no response was initiated, von Frey 
hairs of increasing stiffness were presented. A negative response, followed by the first positive 
response, was considered the response threshold. At the response threshold, hairs of decreasing 
stiffness were applied to the point that there was no response. At this point, von Frey hairs of 
increasing stiffness were applied until the next positive response was recorded. This pattern 
was repeated moving up and down von Frey hairs until a maximum of 4 stimuli had been 
applied after the response threshold. If all responses were only negative or positive, values of 
15.0 g or 0.4 g were assigned respectively. The following formula was used to determine the 
50% paw withdrawal threshold: 50% g threshold = (10^[Xf+kδ])/10,000; where Xf = value of 
the final von Frey hair used (in log units); k = tabular value for the pattern of positive/negative 
responses; 40 δ = mean difference in log units between stimuli (here, 0.224). There was a 1 min 
interval between each von Frey hair application. 
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Cold-evoked hypersensitivity was tested on days 1, 2, 3, 4, 8, 14, and 21 postoperative using 
the acetone test as previously described.41 An acetone bubble (10 µl) was formed at the end of 
a polyethylene tube that was connected to a syringe. With the animals in individual acrylic 
glass enclosures, the bubble was carefully applied to the plantar surface of the foot through the 
perforated floor. Care was taken to ensure that the tubing did not touch the skin. A brisk foot 
withdrawal was considered a positive response. Acetone was applied 5 times to each paw at 
2.5 min intervals. The percent paw withdrawal frequency was calculated.  
 
Electrophysiology 
Recordings from dorsal horn WDR neurons in the region of the L5 spinal segment were 
performed in 11 untreated, 8 saline-treated, 9 neuritis and 6 vinblastine-treated animals. The 
L5 spinal segment innervates much of the plantar surface of the foot that was examined during 
behavioral testing. The methods were based on those previously described.42 Experiments were 
carried out 3-6 days postoperative, i.e. at the approximate peak of pain behaviors (Figure 1). 
Animals were deeply anesthetized (1.75g/kg 25%w/v urethane i.p.), and the body temperature 
maintained at 37°C using a rectal thermistor probe attached to a feedback controlled heat mat 
(Harvard Apparatus, Kent, UK). A mid-sagittal skin incision was made in the lumbar region 
and a short laminectomy (L1-L3 vertebrae) was performed to expose the L5 spinal cord 
segments (i.e. the lumbosacral enlargement). The body of the rat was secured by hip pins and 
the skin flaps were sutured to a metal ring to form a pool. The dura mater was cut to expose 
the spinal cord, and the pool was filled with mineral oil warmed to 37°C. The vertebral column  
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 was fixed in place using clamps attached to the spinous processes immediately rostral and 
caudal of the exposed spinal cord. An insulated tungsten electrode (76 mm, 2.0 M Ohm, 1 µm 
tip, 0.127 mm shaft diameter; World Precision Instruments, Sarasota, Florida, USA) was 
lowered onto the pia surface of the left side of the spinal cord, immediately lateral to the 
posterior spinal artery, using a micro-manipulator. A reference electrode was attached to the 
metal ring.  
The tungsten electrode was slowly lowered into the dorsal horn in 10-50 μm steps to a depth 
of 200 - 900 μm while the ipsilateral foot was stroked and/or gently tapped. Based on a 
histological examination of the spinal cord, this depth was considered the lamina V region (data 
not presented). Once a response could be recorded (i.e. action potentials evoked by innocuous 
brushing of the skin), the center of the receptive field was identified, and the neuron was 
monitored for 3 min to assess ongoing activity levels. Neurons that fired at least once per min 
(0.017 Hz) were considered ongoing. The neuron was then characterized by assessing its 
responses to a range of mechanical stimuli applied to the receptive field. Initially, the center of 
the receptive field was lightly brushed, followed by the application of an ascending series of 
von Frey monofilaments (1, 4, 8, 15, 26, 60 g), after which the receptive field was squeezed 
using curved forceps. Each stimulus was applied for 10 s, with a 10 s interval between stimuli. 
A neuron was considered a wide dynamic range neuron if there was a clear graded response to 
the applied stimuli (Figure 2). For assessment of wind-up, two needle electrodes were inserted 
transcutaneously into the center of the receptive field and sixteen consecutive electrical stimuli 
(0.5 Hz, 2 ms pulse width) were applied at 3x the C-fiber threshold (0.75-5 V). The number of 
action potentials that were evoked by Aβ-, Aδ- and C-fiber neuron input was determined. 
Action potentials with latencies between 0-20 ms, 20-90 ms and 90-350 ms were considered to 
be evoked by Aβ-, Aδ- and C-fiber neurons respectively. Action potentials with latencies  
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 between 350 and 800 ms were classified as post-discharge. Wind-up was calculated from the 
sum of the action potentials between 90 and 800 ms evoked by the 16 consecutive stimuli (i.e. 
total C-fiber-evoked responses and post-discharge) minus the input, which was calculated from 
the sum of the C-fiber evoked-response and post-discharge after the first electrical stimulus 
multiplied by 16. Neurons with positive values were considered to show signs of wind-up. 
Action potentials were amplified (1 K), band-pass filtered (10-5000 Hz) and monitored with 
an oscilloscope. Neuronal activity was digitized and recorded with Spike 2 software 
(Cambridge Electronic Designs, Cambridge, UK) for offline analysis. The total number of 
neurons examined in each animal ranged from 1 to 5. To avoid possible sensitization of the 
skin due to damage, only neurons with non-overlapping receptive fields were examined in the 
same animals.  
Immunohistochemistry 
The expression of c-Fos and substance P in the spinal cord was measured by 
immunohistochemistry. All animals were examined on day 4-5 postoperative. For the 
examination of electrically-evoked c-Fos expression, 12 untreated, 12 neuritis and 12 
vinblastine-treated animals were deeply anaesthetized using pentobarbital (50mg/kg i.p.). In 
four animals from each of the treatment groups, the ipsilateral sciatic nerve was exposed in the 
mid-thigh and stimulated for 5 min at A-fiber strength (3V, 0.05 ms, 5 Hz) using bipolar 
electrodes positioned under the nerve. In another four animals from each group, the nerve was 
stimulated at C-fiber strength (30V, 0.5 ms, 5 Hz; n = 4/group). The voltage necessary to 
stimulate A- and C- fiber neurons was determined during preliminary in vivo electrophysio logy 
experiments (data not presented). After one hour, all animals were transcardially perfused with 
ice-cold 0.1M phosphate-buffered saline (PBS) followed by ice-cold 4% paraformaldehyde (in  
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0.1M PBS, pH 7.4). For examination of substance P, 3 saline-treated, 3 neuritis and 3 
vinblastine-treated animals were anaesthetized using pentobarbital (50mg/kg i.p.) and perfused 
as described above. Note that for c-Fos examination, untreated rather than saline-treated 
animals were examined. Behavioral and electrophysiological assessment of animals confirmed 
that there was negligible difference between saline-treated and untreated groups at the time 
point examined. 
The L5 spinal cord segment was removed and post-fixed in 4% paraformaldehyde for 60 min 
and then transferred to 30% sucrose (in 0.1M phosphate-buffered saline, PBS) overnight at 4oC 
for tissue cryoprotection. Spinal cords were snap frozen in isopentane on dry ice and transverse 
sections were cut at 20 µm using a cryostat (Leica Microsystems, Wetzlar, Germany) and thaw-
mounted on gelatin-coated glass slides. For c-Fos examination, approximately three sections 
from an untreated, neuritis and vinblastine-treated animal that underwent similar electrica l 
stimulation were mounted on each slide. For substance P examination, approximately three 
sections from a saline-treated, neuritis and vinblastine-treated animal were mounted on each 
slide. Two slides were examined for each animal. 
Sections were blocked in 3% normal goat serum (Vector Laboratories, Burlingame, USA) in 
0.2% Triton X-100 for 1 hour at room temperature and incubated overnight at 4oC with c-Fos  
polyclonal rabbit (1:1000; sc-52; Santa Cruz Biotechnology, Dallas, Texas, U.S.A) or 
substance P monoclonal mouse (1:1000; ab14184; Abcam, Cambridge, UK) primary 
antibodies. The sections were then incubated for 1 hour at room temperature with Alexa Fluor 
488 goat anti-rabbit (1:200; Thermo Fisher Scientific, Paisley, UK) or Alexa Fluor 546 goat 
anti-mouse (1:500; Thermo Fisher Scientific, Paisley, UK) conjugated secondary antibodies  
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respectively, and coverslipped using glycerol/PBS mounting medium (Citiflour, London, UK). 
All antibodies were diluted in 3% normal goat serum and 0.2% Triton X-100. Between each 
step, slides were washed in PBS (3 x 5 min). For double labelling experiments, c-Fos 
polyclonal rabbit (1:1000) and NeuN monoclonal mouse (1:100; MAB377; Millipore 
Corporation, Bedford, MA, USA) primary antibodies were incubated together followed by 
Alexa Fluor 488 goat anti-rabbit (1:200; Thermo Fisher Scientific, Paisley, UK) and Alexa 
Fluor 546 goat anti-mouse (1:200; Thermo Fisher Scientific, Paisley, UK) conjugated 
secondary antibodies using the same protocols.  
Slides were viewed under a fluorescence microscope (Leica Microsystems) at 488 and 546 nm 
excitation and photographed at 100x at each wavelength using the same settings. In addition, 
double labelled sections were viewed under a confocal microscope (Leica Microsystems SP8) 
at 488 and 546 nm excitation and photographed at 200x at each wavelength. Non-specific 
staining with secondary antibody was not found in the absence of primary antibody in any case.  
Data analysis 
Data were tested for normality using Shapiro-Wilk tests. For behavioral data, comparisons 
between groups at each time point were performed using two-way analysis of variance 
(ANOVA) followed by Bonferroni’s post hoc tests. For electrophysiological data, comparisons 
between groups were performed using one-way (brushing receptive field, pinching receptive 
field, electrical stimulation of receptive field, and wind-up responses) or two-way ANOVAs 
(von Frey monofilament responses) followed by Bonferroni’s post hoc tests. The proportion of 
ongoing activity was compared using Fisher’s exact tests, and rates were compared using  
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Kruskal Wallis tests. Animal weights were compared using Student’s t-tests. For analysis of c-
Fos labelling, images of the dorsal horn were converted to greyscale using Image J software 
(U. S. National Institutes of Health, Bethesda, Maryland, USA). A region of interest was drawn 
around the superficial dorsal horn as follows: A line was drawn from medial to lateral following 
the posterior surface of the dorsal horn. At the lateral margin, the line was extended anteriorly 
around the curve of the dorsal horn, and a straight line was drawn parallel to the posterior 
surface, medially, to reach the dorsal column. This line was then extended to the posterior 
surface (see insets on Figure 5). The area of the region of interest was measured. The threshold 
was set so that individual cells could be identified. From the resulting binary image, the number 
of positively labelled cells within the region of interest was determined using the ‘analyze 
particles’ function within Image J. To allow for variations in the size of the region of interest, 
the number of positive cells per 0.1 mm2 was calculated for each section, and estimates from 
multiple sections of the same dorsal horn (n = 3 sections from each animal) were averaged. 
Numbers of positive cells per 0.1 mm2 were compared between treatment groups and sides 
using two-way ANOVAs followed by Bonferroni’s post hoc tests. For analysis of substance P 
labelling, images of the dorsal horn were converted to greyscale using Image J software. For 
each image, a greyscale value that was two standard deviations above the mean was determined 
from an area approximately 140 x 75 pixels at the base of the dorsal horn. This value was used 
for thresholding the image. The area of positive labelling (i.e. above the threshold) within the 
superficial lamina was measured. A ratio for the difference in the size of the area expressing 
substance P on the ipsilateral compared to contralateral side was calculated. A value of <1 
indicated the area with positive labelling was less on the ipsilateral compared to contralatera l 
side; a value >1 indicated the area with positive labelling was greater on the ipsilateral  
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compared to contralateral side. Mean area ratios were compared using a one-way ANOVA 
followed by Bonferroni’s post hoc tests. Data are presented as mean +/- standard error of the 
mean (SEM). The ongoing activity rates are presented as median +/- interquartile range (IQR). 
Results 
Development of cutaneous hypersensitivities 
Both neuritis and vinblastine treatment caused reversible signs of tactile-evoked cutaneous 
hypersensitivity (Figure 1(a)). On the ipsilateral side, there was a significant interaction 
between treatment groups and von Frey threshold at each time point (F (14, 112) = 2.25, p < 
0.01, two-way ANOVA; n = 6 per group; Figure 1(a)). Following vinblastine treatment, a 
reduction in threshold was evident as early as day 1 postoperative. A maximum reduction in 
von Frey threshold was observed on day 4-5 in both neuritis and vinblastine-treated groups (p 
< 0.01 compared to saline treatment, Bonferroni’s post hoc test). A reversal was observed by 
day 11 in both groups. On the contralateral side, there was no significant interaction (F (14, 
112) = 1.21, p = 0.28). However, there was a significant main effect for group (F (2, 112) = 
9.84, p < 0.001, two-way ANOVA), with signs of tactile hypersensitivity following vinblast ine 
treatment. Note the duration of the hypersensitivity was shorter compared to the ipsilateral side 
(Figure 1(a)).  
Both neuritis and vinblastine treatment caused reversible signs of cold-evoked cutaneous 
hypersensitivity (Figure 1(b)). On the ipsilateral side, there was a significant interaction 
between treatment groups and paw withdrawal frequency at each time point (F (14, 105) = 
2.86, p < 0.01, two-way ANOVA; Figure 1(b)). Following vinblastine treatment, an increase  
Molecular Pain
14
MPX Express 
Accepted on 13 August, 2018 
This article can be cited as 10.1177/1744806918799581
  
in paw withdrawal frequency was observed as early as day 1 postoperative. A maximum paw 
withdrawal frequency occurred on day 3-4 in both neuritis and vinblastine-treated groups (p < 
0.05 compared to saline treatment, Bonferroni’s post hoc test). A reversal was observed by day 
14 and 21 following vinblastine-treatment and neuritis respectively. On the contralateral side, 
there was also a significant interaction (F (14, 105) = 1.94, p < 0.05), with signs of cold 
hypersensitivity in the neuritis group (Figure 1(b)).  
Electrophysiological properties of wide dynamic range neurons 
Recordings were made from 70 dorsal horn WDR neurons in untreated (n = 19 neurons), saline -
treated (n = 18 neurons), neuritis (n = 20 neurons) and vinblastine-treated (n = 13 neurons) 
animals. The neurons were located at a mean depth of 551 µm (SD = 143; range: 200 – 900 
µm) from the dorsal surface of the spinal cord. Following isolation of each WDR neuron, 
background ongoing activity was recorded. The proportion of neurons with ongoing activity 
was similar between groups, with > 75.0% of neurons firing spontaneously (i.e. > 0.017 Hz; p 
> 0.18, Fisher’s exact tests; Table 1). The median rates of ongoing activity were slow, rangin g 
from 0.06-0.24 Hz, with no significant difference between groups (p = 0.32, Kruskal-Wallis 
test). The pattern of firing was irregular. 
For all WDR neurons, action potentials were evoked in response to both innocuous and noxious 
mechanical stimulation of the ipsilateral distal hind paw (Figure 2(a), (b)). The number of 
action potentials evoked by brushing the center of each receptive field was comparable between 
groups (F (3, 66) = 0.86, p = 0.47, one-way ANOVA). There was a significant interaction 
between treatment group and von Frey monofilament stiffness (F (15, 330) = 1.94, p < 0.05,  
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two-way ANOVA). In the untreated, saline-treated and neuritis groups, mechanical stimula t ion 
of the receptive field with increasing force caused a progressive increase in the number of 
evoked action potentials. In the vinblastine-treated group, the response plateaued with stiffer 
von Frey monofilaments. The number of action potentials evoked with the 60g von Frey 
monofilament was significantly less following vinblastine treatment compared to the untreated 
(p < 0.001) and neuritis groups (p < 0.05, Bonferroni’s post hoc tests). The number of evoked 
action potentials in response to pinching the skin was comparable between groups (F (3, 66) = 
1.90, p = 0.14, one-way ANOVA; Figure 2(b)).  
To assess the effect of neuronal depth on the response to mechanical stimulation of the 
receptive field, WDR neurons were grouped into those ≥ 550 µm (i.e. the mean depth of all 
neurons; maximum depth = 900 µm) from the dorsal surface of spinal cord and those < 550 
µm (minimum depth = 200 µm). In the untreated and saline-treated groups, there was no 
significant interaction between responses evoked by each von Frey filament and neuronal depth 
(untreated: F (5, 85) = 2.22, p = 0.06; saline-treated: F (5, 80) = 2.00, p = 0.09) or main effect 
for depth (untreated: F (1, 17) = 0.03, p = 0.87; saline-treated: F (1, 16) = 0.80, p > 0.39, two-
way ANOVA). In both the neuritis and vinblastine-treated groups, neurons ≥ 550 µm from the 
dorsal surface of the spinal cord responded less to lower force von Frey monofilaments (1-15 
g) compared to those <550 µm from the surface. In the vinblastine-treated group, there was a 
significant interaction between neuronal depth and von Frey monofilament stiffness (F (5, 55) 
= 6.09, p < 0.001, two-way ANOVA). In this group, there was a plateauing in responses from 
neurons < 550 µm from the dorsal surface of the spinal cord to 8-60g von Frey monofilaments 
that was not observed from deeper neurons (Figure 3). In the neuritis group, there was no  
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significant interaction (F (5, 90) = 0.65, p = 0.66) or main effect for depth (F (1, 18) = 2.53, p 
= 0.13, two-way ANOVA). Since the depth of neuron is also related to the size of the animal, 
animal weights were compared between experiments that examined neurons ≥ 550 µm and 
<550 µm from the surface of the spinal cord. There was no significant difference between 
animal weights in the saline-treated, neuritis or vinblastine-treated groups, although there was 
a difference in the untreated group (Table 2). 
Forty-two of the characterized WDR neurons showed signs of wind-up in response to repeated 
electrical stimulation (x16) of the receptive fields (untreated group, n = 10 neurons; saline 
group, n = 11 neurons; neuritis group, n = 11 neurons; vinblastine group, n = 10 neurons; e.g. 
Figure 4(a)). The total number of Aβ-, Aδ- and C-fiber evoked responses (e.g. Figure 4(b)), 
input (i.e. number of action potentials evoked by first pulse x total number of pulses) and post-
discharge of these neurons are summarized in Table 3. There were no significant differences 
between groups in the number of action potentials evoked by Aβ-fiber neurons (F (3, 37) = 
0.85, p = 0.47, one-way ANOVA). Although not quite significant, there was a notable reduction 
in the number of action potentials evoked by Aδ- and C-fiber neurons in the vinblastine-trea ted 
group compared to neuritis (Aδ-fiber neurons: F (3, 37) = 3.174, p < 0.05; C-fiber neurons: F 
(3, 37) = 2.97, p < 0.05, one-way ANOVA; p=0.06 and 0.07 respectively, Bonferroni’s post 
hoc tests). Both input and post-discharge were comparable between groups (input: F (3, 66) = 
1.25, p = 0.30; post-discharge: F (3, 66) = 1.59, p = 0.20, one-way ANOVA).  
The wind-up response was similar between the untreated (mean wind-up = 50.70 ± 9.07 action 
potentials), saline- (mean wind-up = 56.73 ± 13.89 action potentials) and vinblastine-trea ted 
groups (mean wind-up = 43.70 ± 10.05 action potentials). However, in the neuritis group there  
Molecular Pain
17
MPX Express 
Accepted on 13 August, 2018 
This article can be cited as 10.1177/1744806918799581
  
was a significant increase in wind-up response (mean = 115.80 ± 21.67 action potentials, F (3, 
37) = 5.095, p<0.01 one-way ANOVA; p<0.05 compared to untreated, saline-treated and 
vinblastine treated groups, Bonferroni’s post hoc tests; Figure 4(c)).   
c-Fos immunolabeling 
C-Fos was expressed in cells within the superficial lamina of the dorsal horn in all groups (n = 
4 animals in each group; Figure 5(a)). Double-labelling with neuronal marker NeuN confirmed 
that the majority of c-Fos labelled cells were neurons (Figure 5(b)). In the unstimulated groups, 
there was no significant interaction between treatment and side for the numbers of c-Fos 
positive cells (F (2, 6) = 3.84, p = 0.08) or main effect (F (1, 3) = 2.34, p > 0.23, two-way 
ANOVA; Figure 5(c)). Repeated electrical stimulation of the sciatic nerve at C- and A-fiber 
strength caused an increase in c-Fos expression in all groups. In the groups stimulated at C-
fiber strength, there was no significant interaction between treatment and side (F (2, 6) = 1.67, 
p = 0.27). However, there were significant main effects for treatment (F (2, 6) = 6.94, p < 0.05) 
and side (F (1, 3) = 113.80, p < 0.01, two-way ANOVA), with increased c-Fos expression on 
the ipsilateral side in the neuritis and vinblastine-treated groups compared to the untreated 
group and contralateral sides (p < 0.05, Bonferroni’s post hoc tests). In the groups stimula ted 
at A-fiber strength, there was no significant interaction between treatment and side (F (2, 6) = 
1.35, p = 0.33) or main effect (F (2, 6) = 4.682, p > 0.06, two-way ANOVA). 
Substance P immunolabeling 
There was notable substance P immunolabeling in the superficial dorsal horn on both the 
ipsilateral and contralateral sides following saline-treatment and neuritis (n = 3 animals in each  
Molecular Pain
18
MPX Express 
Accepted on 13 August, 2018 
This article can be cited as 10.1177/1744806918799581
  
group; Figure 6(a)). In these groups, the area of dorsal horn expressing substance P was 
comparable between sides (mean ratio [ipsilateral area/contralateral area] = 1.05 ± 0.10 in the 
saline-treated and 0.97 ± 0.07 in the neuritis groups). Following vinblas tine treatment, the area 
of dorsal horn expressing substance P was reduced on ipsilateral compared to contralateral side 
(mean ratio = 0.71 ± 0.09; F (2, 14) = 4.31, p < 0.05 one-way ANOVA; p<0.05, Bonferroni’s 
post hoc test; Figure 6(b)). 
Discussion 
In this study, we have shown that, at approximately the peak of neuropathic pain behaviors, 
localized neuritis leads to an increase in dorsal horn excitability. In contrast, there were no 
signs of an increase in the excitability of WDR neurons following vinblastine treatment, despite 
an increase in c-Fos expression in superficial laminae. In both models, cutaneous 
hypersensitivities and spinal cord changes occur in the absence of significant axonal 
degeneration or demyelination, which was demonstrated in previous studies.1, 3, 33, 38 Taken 
together, these findings indicate that dorsal horn plasticity can be triggered by a relative ly 
minor insult to a nerve. 
The increase in wind-up response from deep WDR neurons following neuritis suggests that 
this neuronal population is sensitized, which is in line with similar reports of increased wind -
up in chronic inflammatory models (e.g. injection of CFA or carrageenan into the hind paw or 
joints).20-22 Consistent with a role for inflammation, the wind-up response did not change 
following vinblastine treatment, since vinblastine is, by virtue of its anti-mitotic properties, 
anti-inflammatory.37 The increase in wind-up following neuritis contrasts from observations in 
models of neuropathic pain that involve cutting or constricting nerves, where similar responses  
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are not reported.11, 12, 14, 43 These discrepancies may reflect differences in the inflammatory 
response between models, as well as the pattern of peripheral ongoing activity, which is reputed 
to drive increases in dorsal horn excitability.44-47 For example, ongoing activity is reported from 
nociceptor neurons following neuritis,3, 6, 48 and in chronic inflammatory models, 49-52 but not 
following vinblastine treatment; in fact, ongoing activity is not increased in any fiber type in 
this model.33, 53 In models of neuropathic pain that involve traumatic nerve injury, ongoing 
activity from nociceptor neurons is rarely observed,54, 55 and when present, rates are extremely 
low.49, 56 Although nociceptors do not synapse directly onto WDR neurons in the lamina V 
region,57 activity from these neurons may contribute indirectly to the increase in wind-up.  
The lack of an increase in ongoing activity from WDR neurons following neuritis and 
vinblastine treatment is consistent with the minor nature of the insult. In particular, it is likely 
to reflect the absence of injury- induced discharge from Aβ-fiber neurons in both models,3, 33, 
48, 53 since many of these neurons synapse directly in lamina V,57  and ongoing activity from 
WDR neurons is reported to be directly driven by injury- induced activity from primary sensory 
neurons.58 In contrast, in models of traumatic nerve injury and chronic hind paw inflammation, 
where ongoing activity from WDR neurons is reported,11, 13-15  ongoing activity from Aβ-fiber 
neurons is also a prominent feature.52, 54, 55, 59  
Although cutaneous mechanical hypersensitivity developed following both neuritis and 
vinblastine- induced axonal transport disruption, WDR neurons did not increase their response 
to direct mechanical stimulation of the receptive field. Instead, following vinblastine treatment, 
there was a notable decrease in the responsiveness of WDR neurons to noxious cutaneous 
mechanical stimulation (i.e. 60 g von Frey monofilament). This decrease may be due to altered  
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neuronal connectivity or inhibition within the dorsal horn, leading to dampening of the 
nociceptive input. For example, activation of descending inhibitory pathways that act on dorsal 
horn neurons has been demonstrated following chronic inflammation of the hind paw.60 A 
similar central mechanism might also explain the reduction in the responses to innocuous 
mechanical stimulation of the receptive fields of WDR neurons at depths of ≥ 550 µm 
compared to those <550 µm. This finding also suggests that there are sub-populations of WDR 
neurons that respond differently to the treatment. The present data cannot however rule out a 
peripheral mechanism, such as a decrease in the mechanical sensitivity of the periphe ral 
terminals of nociceptors. Mechanically sensitive ion channel components are transported to the 
peripheral terminals by fast axonal transport,61 and therefore if transport is impeded, it may 
impact the mechanical sensitivity of nociceptors. Although neuritis also disrupts axonal 
transport, it occurs at a later time point compared to vinblastine treatment,33 which might 
explain why a similar decrease in noxious mechanical sensitivity was not observed.  
The increase in C-fiber stimulated c-Fos expression in superficial laminae in both the neurit is 
and vinblastine-treated groups compared to untreated suggests that these neurons, which were 
not examined electrophysiologically, were also sensitized; c-Fos is an indirect indicator of 
central sensitization, since its expression is driven by the activation of CREB, which mediates 
transcriptional changes that are associated with such mechanisms.24 Our finding is in line with 
previous studies that have examined activity-dependent c-Fos expression in nerve injury 
models.25-27 Although A-fiber stimulated c-Fos expression was increased in all groups, which 
was most likely due to the activation Aβ- and Aδ-fiber nociceptors, there was no significant 
difference in expression between the experimental and untreated groups. This finding contrasts  
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from reports in models of traumatic nerve injury,25, 62, 63 and a model of vincristine- induced 
neuropathy,64 and may reflect the minor nature of the injury. 
Based on the peripheral generator theorem, the transient development of neuropathic pain 
behaviors and increased c-Fos expression in superficial laminae following vinblast ine 
treatment seems incongruous with the reported lack of increased peripheral ongoing activity in 
this model.33, 53 However, the decrease in substance P levels in the dorsal horn suggests that 
nociceptor transmission is altered. This decrease may be caused by the repeated activation of 
nociceptors (such as the activation of mechanically sensitive nociceptive axons at the treatment 
site during limb movements that stretch nerves33, 53), which may cause the depletion of 
neuropeptides from central terminals.65 Alternatively, it may be the result of altered synthes is 
of substance P due to the reduced retrograde transport of trophic factors (e.g. nerve growth 
factor) from the peripheral terminals to the cell bodies; nerve growth factor is considered to 
modulate substance P production.28, 66, 67 The lack of a similar loss of substance P following 
neuritis might reflect the slower time course of axonal transport disruption.    
The development of contralateral cutaneous hypersensitivities following neuritis and 
vinblastine treatment is consistent with a central mechanism. Similar contralateral cutaneous 
hypersensitivities have been reported following nerve injury,16, 68-71 and chronic hind limb 
inflammation.72, 73  Although contralateral dorsal horn neurons were not examined, previous 
studies have demonstrated increased excitability of WDR neurons on the contralateral side 
following nerve injury,16, 17, 74 which may underlie bilateral pain behaviors. Such contralatera l 
changes in the dorsal horn may be driven by the activation of commissural interneurons  
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(Reviewed in 75). However, a systemic mechanism involving the release of inflammatory 
factors from the neuritis site cannot be ruled out.  
In summary, we have shown that both neuritis and vinblastine- induced axonal transport 
disruption, which are relatively minor nerve insults, cause functional changes to dorsal horn 
neurons. Whereas neuritis caused signs of increased excitability of deep WDR neurons, 
vinblastine treatment did not, which indicates mechanistic differences between models and a 
role for inflammation. It is unclear whether deep WDR neurons are involved in the 
development of cutaneous hypersensitivity. The reduction in their responses to mechanica l 
stimulation following vinblastine treatment suggests that these neurons may not be part of the 
mechanism in this model. However, the sensitization of deep WDR neurons to cold stimuli, 
and therefore possible role in cold hypersensitivity, cannot be ruled in either model. Since there 
was clear evidence for an increase in c-Fos expression in lamina I and II in both models, it is 
conceivable that these superficial neurons play a role in the underlying mechanisms. Based on 
the present and previous studies,1, 3, 4 an active neuritis is a possible explanation for neuropathic 
pain in those patients diagnosed with conditions such as non-specific arm or back pain, 
whiplash associated disorder, fibromyalgia and complex regional pain syndrome where an 
obvious nerve injury may not be apparent on routine clinical testing. Data from our studies 
suggests that in this patient group, localized nerve inflammation may drive both peripheral and 
central mechanisms.  
Axonal transport disruption is a major component of any nerve injury, whether the nerve is 
severed or inflamed. Locally treating nerves with vinblastine provides an alternative approach 
for examining the role of axonal transport disruption. With regards to animal welfare, it  
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provides a refined, less severe, model that could in part replace the use of frank nerve injury 
models. Importantly, local vinblastine treatment allows axonal transport disruption to be 
examined along intact axons, which may also be relevant for understanding the mechanisms of 
chemotherapy-induced neuropathy. While many laboratory studies have focused on traumatic 
nerve injury, axonal transport disruption along intact axons may in part underlie many of the 
chronic pain conditions that are seen in the clinic. 
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Treatment Number of 
WDR 
neurons 
%OA Rate, Median 
(IQR) 
Untreated 19 89.5 0.12 (0.13) 
Saline 18 94.4 0.13 (0.19) 
Neuritis 20 75.0 0.06 (0.20) 
Vinblastine 13 76.9 0.24 (0.08) 
OA, ongoing activity; IQR, interquartile range 
Table 1. Levels (%) and rates (Hz) of ongoing activity in WDR neurons.  
 Animal weight, Mean (SEM) 
Treatment Neurons < 550 µm   Neurons ≥ 550 µm  
Untreated 292 (18) 373 (20)* 
Saline 322 (18) 353 (20) 
Neuritis 388 (17) 390 (20) 
Vinblastine 329 (5) 325 (17) 
 
Table 2. Comparison of animal weight in experiments that examined WDR neurons < 550 µm 
and  ≥ 550 µm from the dorsal surface of the spinal cord. * p < 0.05 (Student’s t-test).  
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Table 3. A comparison of the mean total electrically-evoked responses of WDR neurons in 
untreated, saline-treated, neuritis and vinblastine-treated groups. Data is expressed as mean 
number of spikes (SEM). 
  
 Treatment group 
 Untreated Saline Neuritis Vinblastine 
Aβ-fiber 7.90 (3.57) 16.64 (8.09) 12.30 (6.47) 4.60 (2.00) 
Aδ-fiber 29.10 (6.92) 46.09 (11.84) 50.00 (8.88) 15.60 (5.87)  
C-fiber 209.90 (27.68) 158.36 (20.52) 229.70 (35.27) 129.40 (21.18) 
Input 233.60 (31.21) 162.91 (31.47) 224.00 (46.86) 132.80 (33.23) 
Post-
discharge 
74.40 (12.85) 61.27 (16.98) 110.10 (24.47) 47.10 (15.31) 
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Figure 1. Development of cutaneous hypersensitivities. (a) Tactile- and (b) cold-evoked 
hypersensitivities in saline-treated, neuritis and vinblastine-treated groups (n = 6 animals / 
group). Ipsilateral (left) and contralateral (right) data are shown for each test.  Each data point 
represents the mean of 6 animals.  * p < 0.05, ** p < 0.01, *** p < 0.001 comparing neuritis to 
saline-treated group; † p<0.05, †† p<0.01 comparing vinblastine-treated to saline-treated 
group; # p<0.05, ## p<0.01, ### p<0.001 comparing neuritis to vinblastine-treated group (two-
way ANOVA followed by Bonferroni’s post hoc tests at each time point). Error bars = SEM. 
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Figure 2. Responses of WDR neurons to mechanical stimulation of the receptive field. (a) An 
example trace from a saline-treated animal, which shows action potentials evoked by lightly 
brushing the receptive field, applying von Frey hairs of ascending stiffness and pinching the 
skin with curved forceps. (b) The mean number of action potentials elicited by brushing, von 
Frey monofilaments and pinching the skin in untreated, saline-treated, neuritis and vinblastine-
treated animals. Note the decreased response to stiffer von Frey monofilaments and pinching 
in the vinblastine treated group. n = 19, 18, 20 and 13 WDR neurons in the untreated, saline -
treated, neuritis and vinblastine treated group respectively. * p < 0.05, *** p < 0.001 Two-way 
ANOVA followed by Bonferroni’s post hoc test. Error bars = SEM. 
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Figure 3. Mechanical responses of WDR neurons based on depth of neuron within the dorsal 
horn. n = 7, 8, 9 and 7 < 550 µm and 12, 10, 11 and 6 ≥ 550 µm from dorsal surface of spinal 
cord in the untreated, saline-treated, neuritis and vinblastine-treated groups respectively. * p < 
0.05 Two-way ANOVA followed by Bonferroni’s post hoc tests. 
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Figure 4. Wind up responses. (a) Typical wind up response from a neuritis animal. The center 
of the receptive field was electrically stimulated 16 times at 3x C-fiber threshold (arrows). (b)  
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Expanded section of trace (* on part a), showing action potentials evoked by electrica l 
stimulation. Action potentials were classified as Aβ, Aδ or C fiber-evoked based on the 
following latencies: Aβ, 0-20 ms; Aδ, 20-90 ms; C, 90-350 ms. Action potentials that occurred 
at a latency of 350-800 ms were considered post-discharge. (c) A comparison of the mean wind 
up responses of WDR neurons in untreated, saline-treated, neuritis and vinblastine-trea ted 
groups. Wind-up was calculated as the sum of action potentials between 90 and 800 ms 
produced by 16 consecutive stimuli minus the input. n = 10, 11, 11 and 10 WDR neurons in 
the untreated, saline-treated, neuritis and vinblastine-treated groups respectively.  *p < 0.05, 
** p < 0.01 (one-way ANOVA followed by Bonferroni’s post hoc tests). Error bars = SEM. 
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Figure 5. Electrical stimulation-activated c-Fos expression in the L5 dorsal horn. (a) Example 
images of c-Fos expression (green staining) in the ipsilateral dorsal horn following vinblast ine  
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treatment and neuritis. Prior to removal of the tissue, animals received either 5 min repeated 
stimulation of the sciatic nerve at C- (middle) or A-fiber strength (right), or no stimula t ion 
(left).  The majority of c-Fos positive cells were located in the superficial laminae. Note inserts 
that represent the respective image thresholding used for ImageJ analysis. (b) Colocaliza t ion 
of c-Fos (green) with NeuN (red). (c) Mean number of c-Fos positive cells per 0.1 mm2 in each 
group (n = 4 animals in each group). † p < 0.05, †† p < 0.01 comparing between treatments; * 
p < 0.05, ** p < 0.01 comparing between sides (two-way ANOVA followed by Bonferroni’s 
post hoc tests).  IF, Immunofluorescent. Error bars = SEM. 
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Figure 6. Substance P expression in the dorsal horn. (a) Typical example images of substance 
P expression in the L5 region of the dorsal horn in saline-treated, vinblastine-treated and 
neuritis groups. The majority of expression is observed within the superficial lamina (red 
staining). (b) Mean ratios of the dorsal horn area expressing substance P. Calculation was made 
by dividing the ipsilateral area by the contralateral area. n = 3 animals in each group. * p < 0.05 
(one-way ANOVA followed by Bonferroni’s post hoc test). Error bars = SEM. 
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